During the past decade, Jerome Golden Center for Behavioral Health conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jerome Golden Center for Behavioral Health" #1 collaborator was "Otsuka America Pharmaceutical" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Jerome Golden Center for Behavioral Health" are "Schizophrenia" (2 trials) and "Schizophrenia, Schizoaffective Disorder" (1 trials). Many other conditions were trialed in "Jerome Golden Center for Behavioral Health" in a lesser frequency.

Most popular intervention types in "Jerome Golden Center for Behavioral Health" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Any FDA approved antipsychotic agent" (1 trials), "BI 425809" (1 trials), "RO6889450" (1 trials) and "aripiprazole long acting injectable formulation" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jerome Golden Center for Behavioral Health" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Jerome Golden Center for Behavioral Health". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Jerome Golden Center for Behavioral Health, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Jerome Golden Center for Behavioral Health, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".